Palladio Biosciences
0 followers
Palladio Biosciences, Inc., is a Centessa company. Their first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes numerous fluid-filled cysts to grow in both kidneys. It is a life-limiting, chronic and progressive d... Read more
Org chart
Alex Martin
CEO
Alex Martin
Collapse
Lorenzo Pellegrini
Founder & COO
Ron Dadino
VP of CMC & Manufacturing Head of Quality
Amy Murnane
VP of Project Management
Marcus Abraitis
VP of Finance
Milena Kanova
VP of Clinical Operations
Similar companies
Thermo Fisher Scientific
141 followers
Genentech
142 followers
Gilead Sciences
119 followers
Vertex Pharmaceuticals
50 followers
Roivant Sciences
56 followers
Alexion Pharmaceuticals
32 followers
Ionis Pharmaceuticals
22 followers
BeiGene
18 followers
Guardant Health
12 followers
Exelixis
11 followers
Cytokinetics
11 followers
Discover companies